Elizabeth H.z. Thompson - 01 Jul 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP, Research & Development
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Jul 2021
Net transactions value: -$578,381
Form type: 4
Filing time: 02 Jul 2021, 17:02:14 UTC
Previous filing: 10 May 2021
Next filing: 06 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise		+12,077	+77%		27,717	01 Jul 2021	Direct	F1
transaction	HZNP	Ordinary Shares	Tax liability	$578,381	-5,988	-22%	$96.59	21,729	01 Jul 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units	Options Exercise	$0	-12,077	-100%	$0.000000^*	0	01 Jul 2021	Ordinary Shares	12,077		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.